Emerging markets asset manager Ashmore (ASHM) dives 11.1% to 363.4p after revealing a large net outflow of money from clients to the tune of $3.5 billion.


Global online fashion and beauty retailer ASOS (ASC:AIM) falls 1.6% to £67.50 despite reporting impressive growth rates for the first four months to end-December. Total sales rose 37% to £342.6 million, with UK retail sales increasing by the same percentage to £133.7 million, helped by another strong Christmas showing. A lack of profit upgrades prompts investors to book profits in the highly-rated retailer.


A confident trading update from electronics repair specialist Regenersis (RGS:AIM) helps to revive the share price, up 1.7% to 312p. We look at the news in more detail here.


A solid trading update from insurance claims outsourcer Quindell (QPP:AIM) fails to convince all septics with questions still raised by some analyst over cash generation. The stock drifts 0.25p to 22p, having doubled during 2013.


UK onshore oil and gas play Egdon Resources (EDR:AIM) continues to advance, up 31% to 18.8p. after yesterday's £29.3 million farm-out deal with French major Total (FP:PA) for its shale gas assets in the East Midlands.


Men's suit hire specialist Moss Bros (MOSB) moves 20% higher to 89p as a Christmas trading statement triggers forecast upgrades. Like-for-like sales grew by 12.9% over the five weeks to 11 January. As a result, the £74 million cap now expects to beat full-year profit estimates and close the year to 25 January with £28 million cash. It announces an accelerated and progressive dividend policy.


Countrywide (CWD) slips 3.4% 597.7p as investors take profits following a positive update from the property services group. Its profits for 2013 will be at the top end of expectations after its income reached £171 million in the final quarter of the year.


A contract win with French engineering giant Thales gets shares in training manager NetDimensions (NETD:AIM) rallying 3.5% to a record 73.5p.


Russian oil and gas producer Volga Gas (VGAS:AIM) gushes up 8.2% to 110.1p as it announces 2013 output up 46% year-on-year to 2,922 barrels of oil equivalent per day (boepd). The company expects to report revenues of approximately $34 million for last year, a 21% increase on 2012.


Speciality drug company Alliance Pharma (APH:AIM) dips 3.9% to 37p on news that its profits will meet expectations this year. It has also bought thyroid product Irenat in Germany.


Agriculture, food and engineering combine Carr's Milling Industries (CRM), a running Shares Play of the Week, cheapens 3.8% to £16.02 despite flagging a solid start to the year against tough comparatives.


Recruitment consultant Michael Page (MPI) falls 3.3% to 473.05p after reporting a 2.9% drop in permanent job placements. This is the higher-margin side of the staffing business, so investors are naturally disappointed.


The market is encouraged by drill results from Kibo Mining's (KIBO:AIM) Imweru gold project in Tanzania, sending the share price up 11.1% to 5p. Chief executive officer Louis Coetzee says the results 'exceed' the company's expectations.


Cannabinoid-focused medicine company GW Pharmaceuticals (GWP:AIM) falls 2.8% to 249.7p despite Ipsen agreeing to distribute its Sativex spray for multiple sclerosis in South America.


Specialist pharma Allergy Therapeutics (AGY:AIM) rises 3.1% to 8.3p on a 12% revenue growth in the first half, driven by growth across its portfolio and a foreign exchange windfall.


Investors are taking their money off the table at compliance software microcap Ideagen (IDEA:AIM) despite 16% organic revenues and headline growth of 43%. The shares fall 6% to 31.62p, although this is on the back of a near-40% rally over the past three months.

Issue Date: 14 Jan 2014